Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Broc A. Flores"'
Autor:
Hong Fan, Georgia B. McGaughey, Izzat T. Raheem, Mona Purcell, Liza Gantert, Marie A. Holahan, Youwei Yan, Sean M. Smith, Kerry Riffel, Xiangjun Meng, Paul J. Coleman, Jeffrey L. Evelhoch, Wai-Si Eng, Eric D. Hostetler, Aniket Joshi, Christopher D. Cox, John J. Renger, Broc A. Flores
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 25:4893-4898
Phosphodiesterase 10A (PDE10A) inhibition has recently been identified as a potential mechanism to treat multiple symptoms that manifest in schizophrenia. In order to facilitate preclinical development and support key proof-of-concept clinical trials
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::25771a4490bc96538346e9692b6a3f4b
https://doi.org/10.1016/j.bmcl.2015.05.080
https://doi.org/10.1016/j.bmcl.2015.05.080
Autor:
Christopher D, Cox, Eric D, Hostetler, Broc A, Flores, Jeffrey L, Evelhoch, Hong, Fan, Liza, Gantert, Marie, Holahan, Waisi, Eng, Aniket, Joshi, Georgia, McGaughey, Xiangjun, Meng, Mona, Purcell, Izzat T, Raheem, Kerry, Riffel, Youwei, Yan, John J, Renger, Sean M, Smith, Paul J, Coleman
Publikováno v:
Bioorganicmedicinal chemistry letters. 25(21)
Phosphodiesterase 10A (PDE10A) inhibition has recently been identified as a potential mechanism to treat multiple symptoms that manifest in schizophrenia. In order to facilitate preclinical development and support key proof-of-concept clinical trials
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3653efc48d65eecac08112ba08a76246
https://pubmed.ncbi.nlm.nih.gov/26077491
https://pubmed.ncbi.nlm.nih.gov/26077491